We translate condensate biology into much-needed medicines.
We believe that biomolecular condensates
- create dynamic, liquid compartments in cells
- concentrate important chemistry in space and time
- are central to neurodegeneration, cancer, and other diseases
- will help Dewpoint discover important new drugs
A new biology
Our founders and advisors explain how condensates drive cell function and solve biological mysteries.
Stressed cells form condensates.
Our impact
Condensates play a critical role in a wide range of important, once-intractable diseases. Dewpoint develops drugs that exploit this biology to hit “undruggable” targets.
Opportunities that excite us
- Neurodegeneration
- Cancer
- Inflammation
- Infectious disease
- Metabolic disease
- Rare genetic disorders
Collectively we have...
39
Marketed drugs
110+
Patents
580+
Papers
About us
We are a dynamic young biotech company based in Boston, Dresden, and Berlin that is translating brand-new insights about biomolecular condensates into treatments for the toughest diseases.
Latest News
Dewpoint strives to cultivate an inclusive international community that welcomes and empowers everyone. We reject racism, discrimination, harassment, brutality, and all other manifestations of hate.
We draw strength from diversity.
Join our team
We are looking for passionate—and compassionate—scientists across a diverse set of scientific disciplines, including cell biology, high content cell imaging, biophysics, and proteomics. If that’s you we’d love to hear from you, even if there’s not currently an opening that looks like a perfect fit.



Fascinating science
Mind-bending results that utterly change how we understand disease? That’s a Tuesday—and everybody on the team has a real say on what we do Wednesday.
Good folks
You know that jerk who made life in your last lab miserable? He doesn’t work here. But some of the nicest, smartest, goofiest people you’ll ever meet do.
Ambitious agenda
Interested in changing the way drug discovery is done while producing a whole new generation of treatments? Let's work together to make it happen.
Condensates.com
News, events, resources, and insights by and for the condensate community.
Visit siteCurated by
-
Hydrophobic residues advance the onset of simple coacervation in intrinsically disordered proteins at low densities: Insights from field theoretical simulations studies
Jan 19, 2021
-
Evaluation of Cooling-Induced Liquid-Liquid Phase Separation of Ureido Polymers as a Cold-Shock Stress Granules Model
Jan 18, 2021
-
Interplay between tau and α-synuclein LLPS
Jan 18, 2021
-
Salt Inducible Kinase activation and IRE1-dependent intracellular ATP depletion to form Sec bodies in Drosophila cells.
Jan 18, 2021
-
Quantifying Viscosity and Surface Tension of Multi-Component Protein-Nucleic Acid Condensates
Jan 17, 2021
-
Supramolecular tripeptide self-assembly initiated at the surface of coacervates by polyelectrolyte exchange
Jan 17, 2021
-
Phosphorylation-dependent regulation of messenger RNA transcription, processing and translation within biomolecular condensates
Jan 17, 2021
-
Modeling Elastically Mediated Liquid-Liquid Phase Separation
Jan 16, 2021
-
Effect of prenucleation clusters arising from liquid-liquid phase transition on nucleation in a one-component charged colloidal suspension
Jan 16, 2021
-
Systematic Differences between Current Molecular Dynamics Force Fields To Represent Local Properties of Intrinsically Disordered Proteins
Jan 15, 2021